Akèy › Maladi Stargardt
Etid klinik pou Maladi Stargardt ap rekrite nan Etazini
17 etid pou Maladi Stargardt ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Dallas, TX9 etid
- Boston, MA5 etid
- Gainesville, FL4 etid
- Ann Arbor, MI4 etid
- Portland, OR4 etid
- Miami, FL4 etid
- Cincinnati, OH4 etid
- Houston, TX4 etid
- Phoenix, AZ4 etid
- Baltimore, MD3 etid
- Aurora, CO3 etid
- Pittsburgh, PA3 etid
Pa eta
- Arizona4 etid
- Colorado3 etid
- Florid8 etid
- Kalifòni9 etid
- Maryland5 etid
- Massachusetts5 etid
- Michigan5 etid
- Ohio5 etid
- Oregon4 etid
- Pennsylvania3 etid
- Texas10 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Ap rekriteFaz 1/2
Laj 8 a 55 · Tout sèks · Mizajou Sep 30, 2026 · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
Ap rekriteFaz 3
Laj 8 a 45 · Tout sèks · Mizajou Sep 18, 2026 · NCT07419334The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06319872A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Ap rekriteFaz 1
Laj 6 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07734064Rod and Cone Mediated Function in Retinal Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 5 a 100 · Tout sèks · Mizajou Aug 31, 2026 · NCT02617966A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07425574Phase 1 Study of C.001 in Retinal Degeneration
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07594236Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Inherited Retinal Degenerative Disease Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou May 19, 2026 · NCT02435940Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
Ap rekriteFaz 1/2
Laj 16 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT07439887Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07502664Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Ap rekriteEtid obsèvasyon
Laj 5 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Ap rekriteEtid obsèvasyon
Laj 12 a 65 · Tout sèks · Mizajou Sep 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Ap rekriteFaz 1/2
Laj 12 a 65 · Tout sèks · Mizajou Apr 29, 2025 · NCT06942572A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2025 · NCT06805474Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 8, 2025 · NCT06375239Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.